Participated · Series B · Dec 2025

Logpresso builds a unified security platform that combines open, extensible XDR with AI agent–based security operations to help organizations detect and respond to threats. Its technology features lightweight large language model (sLLM) functionality and can run in closed networks, allowing analysts to conduct natural-language investigations such as asking the system to find and assess potential data exfiltration events. The company is rolling out an alliance program with 14 domestic security vendors and plans to formally launch the XDR product in the first half of next year. Having proven its software-as-a-service capability with multiple Korean customers, Logpresso intends to enter Japan first and then expand into North America and Western Europe. Management is targeting an initial public offering in 2028, with Daishin Securities serving as lead underwriter. Including the new investment, Logpresso has raised a cumulative ₩230 billion (approximately US$170 million) since its 2019 seed round and 2023 Series A. No revenue or user metrics were disclosed in the article.

Participated · Series B · Oct 2023

Medipixel develops AI-based medical software for cardiovascular imaging, including MPXA, which automatically detects and quantifies stenosis on coronary angiography. MPXA is fully automated and completes analyses in 1–2 seconds to support real-time use in the cath lab. The company received Korean regulatory approval in 2021 and obtained FDA clearance in March of this year. Medipixel has completed development of an upgraded analyzer that handles a wider range of vessel angles and of a next-generation product, MPFFR, for functional cardiovascular diagnosis, which it plans to release soon. The company holds six U.S. patents and about 30 domestic patents in cardiovascular diagnosis and analysis, and recently won first place among 351 teams in the MICCAI AI algorithm challenge.

Participated · Series C · Aug 2020

ExoCoBio develops exosome-based regenerative aesthetic products and brands. Founded in 2017 and led by CEO Byong Cho, the company has launched ASCE+™, EXOMAGE™, and CELLTWEET™. Those brands target skin rejuvenation, skin immune-modulation, and scalp rejuvenation. The company raised $9.3m in Series C and pre-IPO funding and has cumulatively raised about $56.3m since founding. ExoCoBio has established a strategic alliance with BENEV Company Inc., an FDA-registered medical aesthetic manufacturer in Orange County, California, to support U.S. market activities. The financing is positioned to support continued commercialization of its exosome product lines and near-term growth initiatives. ExoCoBio Inc. is a pharmaceutical R&D and cosmeceutical company developing exosome-based products. The company produces exosome pharmaceuticals and has launched cosmeceutical brands and products such as EXOMAGE™, Celltweet™ and ASCE+™. ExoCoBio works with exosomes—nano-vesicles secreted by cells that contain physiologically active substances and can stimulate cellular or tissue regeneration, with applications in skin and hair. The company plans to use recent funding to set up GMP-compliant exosome manufacturing facilities, hire talent, and secure additional commercialization opportunities in the cosmetics industry. Financially, ExoCoBio raised approximately $26.7M in a Series B and has raised about $46M cumulatively, including an $11M Series A in April 2017. The company was established in January 2017 and is led by CEO Byong Cho.

Participated · Series B · Mar 2020

Odd Concepts commercializes PXL, a fashion styling service that uses proprietary machine‑learning and computer vision to recognize, analyze and search images and recommend personalized fashion products. PXL is used by about 100 e‑commerce companies across Korea and APAC (including Singapore, Japan, Indonesia and Thailand) and records over 9 million monthly unique users. The company has gathered billions of data points on consumers and product coordination from three years of commercial service, and holds more than 60 patents (registered and filings) at home and abroad. Odd Concepts has placed first in about 10 domestic and international benchmark tests, positioning it as a deep‑tech leader in fashion commerce. The company plans to expand its business across APAC markets and earlier this year moved to accelerate regional growth by acquiring Singaporean startup SEACRUX to extend contextual targeting ad capabilities. Its accumulated investments total about USD10M, providing capital to support regional expansion and further product development.

Led · Series A · Jan 2020

SuperTree develops blockchain-based games and dApp infrastructure, and is best known for the titles CryptoDozer and DozerBird. Both games are distributed apps that run without a centralized server, using blockchain storage and smart contracts. The titles were launched in the Samsung Blockchain Wallet last year and were introduced at the Samsung Developer Conference in the U.S. SuperTree is building a tournament platform called PlayDapp to enable real-time competition and a customer-to-customer marketplace for direct trading of in-game items. CEO Choi Sungwone said the company plans to ramp up development of C2C marketplaces and tournaments and move toward commercialization after verification at home and abroad. The team includes developers with experience at Netmarble and NCSoft, and the company recently secured new funding to support those efforts.